ArticlePharmaceutics2022

Design, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia.

Jeanluc Bertrand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.